Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Aufgaben und Organisation von Neuro-Intensivstationen Kapitel lesen Erstes Kapitel lesen

2015 | OriginalPaper | Buchkapitel

32. Infektionen

verfasst von : Matthias Klein, PD Dr., Hans-Walter Pfister, Prof. Dr., Erich Schmutzhard, Prof. Dr., Uta Meyding-Lamadé, Prof. Dr., Corinna Schranz, Dr., Gabriele Arendt, Prof. Dr., Raimund Helbok, PD Dr., Bettina Pfausler, PD Dr., André Grabowski, Dr., Bodo Kress, Prof. Dr., Ronny Beer, PD Dr.

Erschienen in: NeuroIntensiv

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

In diesem Kapitel werden zunächst die für die Neurointensivmedizin wesentlichen bakteriellen Infektionen (Meningitis, spinale und Hirnabszesse, Spondylodiszitis, septisch-embolische Herdenzephalitis) abgehandelt, die trotz gezielt eingesetzter Antibiotika und neurochirurgischer Therapieoptionen noch mit einer erheblichen Morbidität und Mortalität behaftet sind. Besonderheiten wie neurovaskuläre Komplikationen, die Tuberkulose des Nervensystems, Neuroborreliose, Neurosyphilis und opportunistische Infektionen bei Immunsuppressionszuständen finden hierbei besondere Berücksichtigung. Der zweite Teil dieses Kapitels behandelt akute und chronische Virusinfektionen des ZNS sowie in einem gesonderten Abschnitt die HIVInfektion und HIV-assoziierte Krankheitsbilder sowie Parasitosen und Pilzinfektionen, die in Industrieländern seit Einführung der HAART bei HIV zwar eher seltener, aber mit zunehmender Globalisierung auch in unseren Breiten immer noch anzutreffen sind.
Literatur
1.
Ajdukiewicz KM, Cartwright KE, Scarborough M et al (2011) Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis 11:293–300PubMedPubMedCentralCrossRef
2.
Auburtin M, Wolff M, Charpentier J et al (2006) Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 34:2758–2765PubMedCrossRef
3.
Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D (2010) Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 75:1533–1539PubMedCrossRef
4.
Brouwer MC, McIntyre P, de Gans J, Prasad K, van de BD (2010) Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 9:CD004405PubMed
5.
Casado FJ, Blanco QA (2001) ProcalcitoninA new marker for bacterial infection. An Esp Pediatr 54:69–73CrossRef
6.
Chaudhuri A, Martin PM, Kennedy PG et al (2008) EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 15:649–659PubMedCrossRef
7.
de Gans J, van de Beek D (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347:1549–1556PubMedCrossRef
8.
Dubos F, Korczowski B, Aygun DA et al (2008) Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med 162:1157–1163PubMedCrossRef
9.
Durand ML, Calderwood SB, Weber DJ et al (1993) Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328:21–28PubMedCrossRef
10.
Hasbun R, Abrahams J, Jekel J, Quagliarello VJ (2001) Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 345:1727–1733PubMedCrossRef
11.
Heckenberg SG, de Gans J, Brouwer MC et al (2008) Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 87:185–192CrossRef
12.
Heckenberg SG, Brouwer MC, van der Ende A, van de Beek D (2012) Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology 79:1563–1569PubMedCrossRef
13.
Imohl M, van der Linden M, Mutscher C, Reinert RR (2010) Serotype distribution of invasive pneumococcal disease during the first 60 days of life. Vaccine 28:4758–4762PubMedCrossRef
14.
Kastenbauer S, Pfister HW (2003) Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 126(Pt 5):1015–1025PubMedCrossRef
15.
Klein M, Koedel U, Pfister HW (2006) Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? Prog Neurobiol 80:269–280PubMedCrossRef
16.
Klein M, Paul R, Angele B, Popp B, Pfister HW, Koedel U (2006) Protein expression pattern in experimental pneumococcal meningitis. Microbes Infect 8:974–983PubMedCrossRef
17.
Klein M, Obermaier B, Angele B et al (2008) Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis 198:1028–1036PubMedCrossRef
18.
Klein M, Pfister HW, Leib SL, Koedel U (2009) Therapy of community-acquired acute bacterial meningitis: the clock is running. Expert Opin Pharmacother 10:2609–2623PubMedCrossRef
19.
Klein M, Koedel U, Kastenbauer S et al (2010) Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis: past as prologue: delayed stroke as a parainfectious process of bacterial meningitis? Neurology 75:193–194PubMedCrossRef
20.
Klein M, Koedel U, Pfefferkorn T, Zeller G, Woehrl B, Pfister HW (2011) Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis. Crit Care 15:R281PubMedPubMedCentralCrossRef
21.
Koedel U, Klein M, Pfister HW (2010) New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis 23:217–223PubMedCrossRef
22.
Kramer AH, Bleck TP (2008) Neurocritical care of patients with central nervous system infections. Curr Treat Options Neurol 10:201–211PubMedCrossRef
23.
Krysan D (2009) Serum procalcitonin levels aid in distinguishing bacterial from aseptic meningitis in children. J Pediatr 154:773PubMedCrossRef
24.
Molyneux EM, Walsh AL, Forsyth H et al (2002) Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 360:211–218PubMedCrossRef
25.
Molyneux EM, Kawaza K, Phiri A et al (2014) Glycerol and Acetaminophen as Adjuvant Therapy Did Not Affect the Outcome of Bacterial Meningitis in Malawian Children. Pediatr Infect Dis J 33:214–216PubMedCrossRef
26.
Mourvillier B, Tubach F, van de Beek D et al (2013) Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA 310:2174–2183PubMedCrossRef
27.
Nathan BR, Scheld WM (2002) The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis 22:155–165PubMed
28.
Nguyen TH, Tran TH, Thwaites G et al (2007) Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 357:2431–2440PubMedCrossRef
29.
Ntziora F, Falagas ME (2007) Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 41:296–308PubMedCrossRef
30.
Pfister HW, Feiden W, Einhaupl KM (1993) Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol 50:575–581PubMedCrossRef
31.
Pfister HW, Bühler R, Eiffert H, Nau R, Weber JR (2012) Ambulant erworbene bakterielle (eitrige) Meningitis. Leitlinien für Diagnostik und Therapie in der Neurologie der DGN. Thieme, Stuttgart, S 494–504
32.
Proulx N, Frechette D, Toye B, Chan J, Kravcik S (2005) Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 98:291–298PubMedCrossRef
33.
RKI (Robert Koch Institut) (2009) Empfehlung und Begründung einer postexpositionellen Meningokokken-Impfung. Epidemiol Bull 31:314–317
34.
RKI (Robert Koch Institut) (2010) Meningokokkenerkrankungen. RKI Ratgeber Infektionskrankheiten – Merkblätter für Ärzte. www.​rki.​de
35.
RKI (Robert Koch Institut) (2011) Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Deutschland. Epidemiol Bull 3:21
36.
RKI (Robert Koch Institut) (2013) Stellungnahme der Ständigen Impfkommission (STIKO) am Robert Koch-Institut (RKI) zum Stand der Bewertung des neuen Meningokokken-B-Impfstoffs Bexsero. Epidemiol Bull 49:495–498
37.
RKI (Robert Koch Institut) (2014) Jahresstatistik meldepflichtiger Infektionskrankheiten, Deutschland 2013. Robert Koch Institut. Epidemiol Bull 16:144
38.
Rupprecht TA, Pfister HW (2005) Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol 12:536–542PubMedCrossRef
39.
Sakushima K, Hayashino Y, Kawaguchi T, Jackson JL, Fukuhara S (2011) Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect 62:255–262PubMedCrossRef
40.
Schut ES, Brouwer MC, de Gans J, Florquin S, Troost D, van de Beek D (2009) Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 73:1988–1995PubMedCrossRef
41.
Southwick FS (1995) Septic thrombophlebitis of major dural venous sinuses. Curr Clin Top Infect Dis 15:179–203PubMed
42.
Stephens DS, Greenwood B, Brandtzaeg P (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196–2210PubMedCrossRef
43.
van de Beek D, de Gans J, McIntyre P, Prasad K (2007) Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 1:CD004405PubMed
44.
van de Beek D, Farrar JJ, de Gans J et al (2010) Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 9:254–263PubMedPubMedCentralCrossRef
45.
van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR (2012) Advances in treatment of bacterial meningitis. Lancet 380:1693–1702PubMedCrossRef
46.
Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J (2006) Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 5:123–129PubMedCrossRef
47.
Winkler F, Kastenbauer S, Yousry TA, Maerz U, Pfister HW (2002) Discrepancies between brain CT imaging and severely raised intracranial pressure proven by ventriculostomy in adults with pneumococcal meningitis. J Neurol 249:1292–1297PubMedCrossRef
48.
Baddley JW, Salzman D, Pappas PG (2000) Fungal brain abscess in transplant recipients: epidemiologic microbiologic, and clinical features. Clin Transplant 16:419–424CrossRef
49.
Bernal E, Munoz A, Nunez ML, Cano A (2010) Multidrug-resistant spinal tuberculosis and giant paraspinal abscess. Med Clin (Barc) Nov 10 (Epub ahead of print)
50.
Boviatsis EJ, Kouyialis AT, Stranjalis G et al (2003) CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review. Neurol Sci 24:97–102PubMedCrossRef
51.
Chang MC, Wu HT, Lee CH et al (2006) Tuberculous spondylitis and pyogenic spondylitis: comparative magnetic resonance imaging features. Spine 31:782–288PubMedCrossRef
52.
Demir MK, Hakan T, Kilicoglu G et al (2007) Bacterial brain abscesses: prognostic value of an imaging severity index. Clin Radiol 62:564–572PubMedCrossRef
53.
Greenberg BM (2008) Central nervous system infections in the intensive care unit. Semin Neurol 28:682–689PubMedCrossRef
54.
Honda H, Warren DK (2009) Central nervous system infections: meningitis and brain abscess. Infect Dis Clin North Am 23:609–623PubMedCrossRef
55.
Jansson AK, Enblad P, Sjolin J (2004) Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. Eur J Clin Microbiol Infect Dis 23:7–14PubMedCrossRef
56.
Kang K, Lim I, Roh JK (2007) Positron emission tomographic findings in a tuberculous brain abscess. Ann Nucl Med 21:303–306PubMedCrossRef
57.
Kao PT, Tseng HK, Liu CP et al (2003) Brain abscess: clinical analysis of 53 cases. J Microbiol Immunol Infect 36:129–136PubMed
58.
Kupila L, Rantakokoo-Jalava K, Jalava J et al (2003) Aetiological diagnosis of brain abscesses and spinal infections: application of broad range bacterial polymerase chain reaction analysis. J Neurol Neurosurg Psychiatry 74:728–733PubMedPubMedCentralCrossRef
59.
Kutlay M, Colak A, Yildiz S et al (2005) Stereotactic aspiration and antibiotic treatment combined with hyperbaric oxygen therapy in the management of bacterial brain abscess. Neurosurg 57:1140–1146CrossRef
60.
Le Moal G, Landron C, Grollier G et al (2003) Characteristics of brain abscess with isolation of anaerobic bacteria. Scand J Infect Dis 35:318–321PubMedCrossRef
61.
Leuthardt EC, Wippold FJ, Oswood MC et al (2002) Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses. Surg Neurol 58:395–402PubMedCrossRef
62.
Livraghi S, Melancia JP, Antunes jL (2003) The management of brain abscesses. Adv Tech Stand Neurosurg 28:285–313PubMed
63.
Lu CH, Chang WN, Lui CC (2006) Strategies for the management of bacterial brain abscess. J Clin Neurosci 13:979–985PubMedCrossRef
64.
Lumbiganon P, Chaikitpinyo A (2007) Antibiotics for brain abscesses in people with cyanotic congenital heart disease. Cochrane Database Syst Rev 18:CD004469
65.
McClelland S, Hall WA (2007) Postoperative central nervous system infection: incidence and associated factors in 2111 nerosurgical procedures. Clin Infect Dis 45:55–59PubMedCrossRef
66.
Mueller-Mang C, Castillo M, Mang TG et al (2007) Fungal versus bacterial brain abscesses: is diffusion-weighted MR imaging a useful tool in the differential diagnosis? Neuroradiol 49:651–657CrossRef
67.
Pfister HW, Feiden W, Einhäupl KM (1993) The spectrum of complications during bacterial meningitis in adults: Results of a prospective clinical study. Arch Neurol 50:575–580PubMedCrossRef
68.
Saez-Llorens X (2003) Brain abscess in children. Semin Pediatr Infect Dis 2003 14:108–114CrossRef
69.
Skoutelis AT, Gogos CA, Maraziotis TE et al (2000) Managment of brain abscesses with sequential intravenous/oral antibiotic therapy. Eur J Clin Microbiol Infect Dis 19:332–335PubMedCrossRef
70.
Su TM, Lan CM, Tsai YD et al (2003) Multilocated pyogenic brain abscess: experience in 25 patients. Neurosurgery 52:1075–1079PubMedCrossRef
71.
Tahir MZ, Hassan RU, Enam SA (2010) Management of an extensive spinal epidural abscess from C-1 to the sacrum. J Neurosurg Spine 13:780–783PubMedCrossRef
72.
Tattevin P, Bruneel F, Clair B et al (2003) Bacterial brain abscesses: a retrospective study of 94 patients admitted to an intensive care Unit (1980–1999). Am J Med 115:143–146PubMedCrossRef
73.
The “Infection in Neurosurgery” Working Party of the British Society for Antimicrobial Therapy (2000) The rational use of antibiotics in the treatment of brain abscess. Br J Neurosurg 14:525–530CrossRef
74.
Tsai YD, Chang WN, Shen CC et al (2003) Intracranial suppuration: a clinical comparison of subdural empyemas and epidural abscesses. Surg Neurol 59:191–196PubMedCrossRef
75.
Tseng JH, Tseng MY (2006) Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol 65:557–562PubMedCrossRef
76.
Tung GA, Rogg JM (2003) Diffusion-Weighted Imaging of Cerebritis. Am J Neuroradiol 24:1110–1113PubMed
77.
Visani P, Schmutzhard E, Trinka E et al (2006) Subcortical deficit pattern after brain abscess: a neuropsychological study. Eur J Neurol 13:599–603PubMedCrossRef
78.
Wang VY, Chou D, Chin C (2010) Spine and spinal cord emergencies: vascular and infectious causes. Neuroimaging Clin N Am 20:639–650PubMedCrossRef
79.
Yilmaz MH, Mete B, Kantarci F et al (2007) Tuberculous, brucellar and pyogenic spondylitis: comparison of magnetic resonance imaging findings and assessment of its value. South Med J 100:613–614PubMedCrossRef
80.
Younis RT, Lazar RH, Anand VK (2002) Intracranial complications of sinusitis: a 15-year review of 39 cases. Ear Nose Throat J 81:636–638 (640–642, 644)PubMed
81.
Aksamit AJ (2010) Whipple’s disease of the central nervous system. Handb Clin Neurol 96:231–237PubMedCrossRef
82.
83.
Andronikou S, Smith B, Hatherhill M et al (2004) Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol 34:876–885PubMedCrossRef
84.
Asselman V, Thienemann F, Pepper DJ et al (2010) Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS 24:2871–2876PubMedCrossRef
85.
Banerjee B, Petersen K (2009) Psychosis following mycoplasma pneumonia. Mil Med 174:1001–1004PubMedCrossRef
86.
Bhigjee AI, Padayachee R, Paruk H et al (2007) Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis 11:348–354PubMedCrossRef
87.
Black DF, Aksamit AJ, Morris JM (2010) MR imaging of central nervous system Whipple disease: a 15-year review. AJNR Am J Neuroradiol 31:1493–1497PubMedCrossRef
88.
Boillat N, Greub G (2007) Rickettsiosis: a clinical approach. Rev Med Suisse 16:1222–1227
89.
90.
Bross JE, Gordon G (1991) Nocardial Meningitis: Case Reports and Review. Rev Infect Dis 13:160–165PubMedCrossRef
91.
Christmann D, Hansmann Y, Remy V et al (2002) Tick-borne neurological diseases. Rev Neurol 158:993–997PubMed
92.
Chotmongkol V, Teerajetgul Y, Yodwut C (2006) Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults. SE Asian J Trop Med Public Health 37:948–952
93.
Cunha BA, Pherez FM (2009) C. pneumoniae community-acquired pneumonia (CAP) in mimicking Mycoplasma pneumonia meningoencephalitis complicated by asthma. Heart Lung 38:530–533PubMedCrossRef
94.
Dumler J, Madigan JE, Pusterlia N et al (2007) Ehrlichioses in Humans: Epidemiology, clinical Presentations, Diagnosis and Treatment. Clin Infect 45:45–51CrossRef
95.
Fenollar F, Puechal X, Raoult D (2007) Whipple’s disease. N Engl Med 356:55–56CrossRef
96.
Garcia Monco JC (2006) Tuberculosis and other mycobacterial Infections. In: Noseworthy JH (Hrsg) Neurological Therapeutics – Principles and Practice, 2. Aufl. Informa Health Care Abingdon, Oxon, S 1011–1020
97.
Godia CE, Esteve CM, Campello RA et al (2007) Cerebral saltwasting syndrome due to infectious diseases of the central nervous system. Med Clin 128:278–279CrossRef
98.
Gouriet F, Lepidi H, Habib G et al (2007) From Cat Scratch disease to endocarditis, the possible natural history of Bartonella henselae infection. BMC Inf Dis 7:30–35CrossRef
99.
Hainard A, Tiberti N, Robin X et al (2010) Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis. Trop Med Int Health 16:119–126PubMedCrossRef
100.
Hongo I, Bloch KC (2006) Ehrlichia infection of the central nervous system. Curr Treat Options Neurol 8:179–184PubMedCrossRef
101.
Jha DK, Mishra V, Choudhary A et al (2007) Factors affecting the outcome of neuroendoscopy in patients with tuberculous meningitis hydrocephalus: a preliminary study. Surg Neurol 68:35–41PubMedCrossRef
102.
Inan AS, Ceran N, Erdem I et al (2010) Neurobrucellosis with transient ischemic attack, vasculopathic changes, intracerebral granulomas and basal ganglia infarction: a case report. J Med Case Reports 4:340–342PubMedCentralCrossRef
103.
Kalita J, Misra UK, Ranjan P (2007) Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis. Eur J Neurol 14:33–37PubMedCrossRef
104.
Kazar J (2005) Coxiella burnetii infection. Ann NY Academy Sci 1063:105–114CrossRef
105.
Koskiniemi M (1993) CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis 17:52–57CrossRef
106.
107.
Lee CH, Lui CC, Liu JW (2007) Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma. AIDS Patient Care 21:234–239CrossRef
108.
Lin JJ, Harn JH, Hsu YD et al (1995) Rapid diagnosis of tuberculous meningitis by polymerase chain reaction assay of cerebrospinal fluid. J Neurol 242:147–152PubMedCrossRef
109.
Mahajan SK, Rolain JM, Kanga A, Raoult D (2010) Scrub typhus involving central nervous system, India, 2004–2006. Emerg Infect Dis 16:1641–1643PubMedPubMedCentralCrossRef
110.
Masoodi I, Farooq O, Ahmad I et al (2010) Acute disseminated encephalomyelitis as the first presentation of CNS tuberculosis: report of a case with brief review. Ger Med Sci 8:1–4
111.
Noyola DE, Holder DL, Fishman MA et al (1999) Recurrent encephalopathy in cat-scratch disease. Pediatr Infect Dis 18:567–568CrossRef
112.
Pappas G, Papadimitriou P, Akriditis N et al (2006) The new global map of human brucellosis. Lancet Infect Dis 6:91–99PubMedCrossRef
113.
Pfister HW (2002) Meningits. Kohlhammer, Stuttgart
114.
Prasad K, Singh MB (2008) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008:CD002244
115.
Przybojewski AS, Wilmshurst J (2006) Objective CT criteria to determine the presence of abnormal basal enhancement in children with suspected tuberculous meningitis. Pediatr Radiol 36:687–696PubMedCrossRef
116.
Rafi W, Venkataswamy MM, Ravi V et al (2007) Rapid diagnosis of tuberculous meningitis: a comparative evaluation of in-house PCR assays involving three mycobacterial DNA sequences, IS6110-MPB-64 and 65 kDa antigen. J Neurol Sci 252:163–168PubMedCrossRef
117.
Raoult D, Birg MI, La Scola B et al (2000) Cultivation of the bacillus of Whipple’s disease. N Engl J Med 342:620–625PubMedCrossRef
118.
119.
Roca B, Bahamonde D (2006) Tuberulous Meningitis Presenting with Unusually Severe Hyponatremia. The Mount Sinai J Med 73:1029–1030
120.
Schiffer JT, Sterling TR (2007) Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defic Syndr 44:229–234PubMedCrossRef
121.
Schmutzhard E et al (2008) Atypische erregerbedingte Meningoencephalitis. In: Diener HC (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie, 4. Aufl. Thieme, Stuttgart
122.
Schmutzhard E, Pfister HW (2001) Seltene bakterielle Infektionen des Nervensystems. Akt Neurol 28:373–382CrossRef
123.
Schoeman J, Mansvelt E, Springer P et al (2007) Coagulant and fibrinolytic status in tuberculous meningitis. Pediatr Infect Di J 26:428–431CrossRef
124.
Skiba V, Barner KC (2009) Central nervous system manifestations of Q fever responsive to steroids. Mil Med 174:857–859PubMedCrossRef
125.
Socan M (1994) Chlamydia pneumoniae and meningoencephalitis. N Engl J Med 11:331–406
126.
Srikanth SG, Taly AB, Nagarajan K et al (2007) Clinicoradiological features of tuberculous meningitis in patients over 50 years of age. J Neurol Neurosurg Psychiatr 78:536–538PubMedCrossRef
127.
Tezer H, Kara A, Haliloglu G et al (2008) Mycoplasma pneumonia-associated transverse myelitis with unexpected rapid response to macrolide therapy: a case report. Turk J Pediatr 50:585–588PubMed
128.
Thurtell MJ, Keed AB, Yan M et al (2007) Tuberculous cranial pachymeningitis. Neurology 68:298–300PubMedCrossRef
129.
Wang VY, Chou D, Chin C (2010) Spine and spinal cord emergencies: vascular and infectious causes. Neuroimaging Clin N Am 20:639–650PubMedCrossRef
130.
Yis U, Kurul SH, Cakmakci H, Dirik E (2008) Mycoplasma pneumonia: nervous system complications in childhood and review of the literature. Eur J Pediatr 167:973–978PubMedCrossRef
131.
132.
Blank LJ, Rompalo AM, Erbelding EJ, Zenilman JM, Ghanem KG (2011) Treatment of syphilis in HIV-infected subjects: a systematic review of the literature. Sex Transm Infect 87:9–16PubMedCrossRef
133.
Ghanem KG (2010) Review: Neurosyphilis: A historical perspective and review. CNS Neurosci Ther 16:157–168CrossRef
134.
Hajjaj KN (2010) Status epilepticus revealing syphilitic meningoencephalitis. Acta Neurol Belg 110:263–267PubMed
135.
Halperin JJ (2007) Diagnosis and treatment of the neuromuscular manifestations of Lyme disease. Curr Treat Options Neuro 9:93–100CrossRef
136.
137.
Halperin JJ, Shapiro ED, Logigian E et al (2007) Practice parameter: treatment of nervous system Lyme disease (an evidence based review): report of the Quality of Standards Subcommittee of the American Academy of Neurology. Neurology 69:91–102PubMedCrossRef
138.
Jenke AC, Stoek LM, Zilbauer M, Wirth S, Borusiak P (2011) Facial palsy: Etiology, outcome and management in children. Eur J Paediatr Neurol 15:209–213PubMedCrossRef
139.
Kobayashi J, Nakagawa Y, Tobisawa S, Isozaki E, Koide R (2011) Deterioration of MRI findings related to Jarisch-Herxheimer reaction in a patient with neurosyphilis. J Neurol 258:699–701PubMedCrossRef
140.
Makhani N, Morris SK, Page AV et al (2011) A Twist On Lyme: The challenge of Diagnosing European Lyme Neuroborreliosis. J Clin Microbiol 49:455–457PubMedCrossRef
141.
Richter D, Postic D, Sertour N et al (2006) Delineation of Borrelia burgdorferi sensu lato species by multilocus sequence analysis and confirmation of the delineation of Borrelia spielmanii sp. nov. Int J Syst Evol Microbiol 56:873–881PubMedCrossRef
142.
Robertson J, Guy E, Andrews N et al (2000) European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol 38:2097–2102PubMedPubMedCentral
143.
Roos K (2006) Neurosyphilis. In: Noseworthy JH (Hrsg) Neurological Therapeutics-Principles and Practice, 2. Aufl. Informa Health Care, Abingdon, Oxon, S 1021–1024
144.
Schmutzhard E, Pfausler B, Gasse T et al (1995) Verlauf und Langzeitfolgen der chronischen Neuroborreliose. Wien Med Wochenschr 145:183–186PubMed
145.
van Burgel ND, Oosterloo M, Kroon FP, van Dam AP (2010) Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature. BMC Neurol 10:117–121PubMedPubMedCentralCrossRef
146.
147.
Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme Borreliosis. FEMS Immunol Med Microbiol 49:13–21PubMedCrossRef
148.
Workowski KA, Berman SM (2010) Sexually transmitted diseases treatment. Guidelines 59(RR12):1–110
149.
Wormser GP, Nadelman RB, Dattwyler RJ et al (2000) Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 31:1–14PubMedCrossRef
150.
Abzug MJ, Cloud G, Bradley J, Sanchez PJ, Romero J, Powel D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley RJ, Kimberlin DW (2003) Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 22:335–341PubMed
151.
Adamo MA, Deshaies EM (2008) Emergency decompressive craniectomy for fulminating infectious encephalitis. J Neurosurg 108:174–176PubMedCrossRef
152.
Armangue T, Leypoldt F, Dalmau J (2014) Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 27:361–368PubMedPubMedCentralCrossRef
153.
154.
Baringer JR, Pisani P (1994) Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 36:823–829PubMedCrossRef
155.
Bossart KN, Zhu Z, Middleton D et al (2009) A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. Plos Pathog 5:e1000642PubMedPubMedCentralCrossRef
156.
Casrouge A, Zhang SY, Eidenschenk C et al (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308–312PubMedCrossRef
157.
Center for Disease Control, Prevention (2004) Recovery of a Patient from Clinical Rabies. MMW 53:1171–1173
158.
C D C (1999) Update: Outbreak of Nipah virus – Malaysia and Singapore. MMWR 48:335–337
159.
160.
161.
Cinque P, Bossolasco S, Lundkvist A (2003) Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system. J Clin Virol 26:1–28PubMedCrossRef
162.
Collaborative Antiviral Study Group, http://​clinicaltrials.​gov/​show/​NCT00031486: A Phase III Double-Blind, Placebo-Controlled Trial of Long Term Therapy of Herpes Simplex Encephalitis (HSE): An Evaluation of Valacyclovir (CASG-204), lead sponsor National Institute of Allergy and Infectious Diseases (NIAID)
163.
Corssmit EP, Leverstein-van Hall MA, Portegies P, Bakker P (1997) Severe neurological complications in association with Epstein-Barr virus infection. J Neurovirol 3:460–464PubMedCrossRef
164.
Defang GN, Khetawat D, Broder CC, Quinnan GV Jr. (2010) Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system. Vaccine 29:212–220PubMedPubMedCentralCrossRef
165.
DGN – Deutsche Gesellschaft für Neurologie (2012) Leitlinie „Virale Meningoenzephalitiden“
166.
Falcone S, Post MJ (2000) Encephalitis, cerebritis, and brain abscess: pathophysiology and imaging findings. Neuroimaging Clin N Am 10:333–353PubMed
167.
Fusco D, Krawitz P, LaRussa P, Steinberg S, Gershon A (2010) Jacobs J VZV meningitis following varicella vaccine. J Clin Virol 48:275–277PubMedCrossRef
168.
Granerod J, Cunningham R, Zuckerman M et al (2010) Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 138:783–800PubMedCrossRef
169.
Granerod J, Tam CC, Crowcroft NS, Davies NWS, Borchert M, Thomas SL (2010) Challenge of the unknown: A systematic review of acute encephalitis in non-outbreak situations. Neurology 75:924–932PubMedCrossRef
170.
Gurley ES, Montgomery JM, Hossain MJ et al (2007) Person-to-person transmission of Nipah virus in Bangladeshi community. Emerg Infect Dis 13(7):1031–1037PubMedPubMedCentralCrossRef
171.
Hacohen Y, Deiva K, Pettingill P, Waters P, Siddiqui A, Chretien P, Menson E, Lin JP, Tardieu M, Vincent A, Lim MJ (2014) N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 29:90–96PubMedCrossRef
172.
Haglund M, Forsgren M, Lindh G, Lindquist L (1996) A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis 28:217–224PubMedCrossRef
173.
Hauser SL (2006) Harrison’s Neurology in Clinical Medicine. McGraw-Hill, New York
174.
Henquell C, Chambon M, Bailly JL, Alcaraz S, De Champs C, Archimbaud C, Labbe A, Charbonne F, Peigue-Lafeuille H (2001) Prospective analysis of 61 cases of enteroviral meningitis: interest of systematic genome detection in cerebrospinal fluid irrespective of cytologic examination results. J Clin Virol 21:29–35PubMedCrossRef
175.
Kaiser R (2002) Tick-borne encephalitis (TBE) in Germany and clinical course of the disease. Int J Med Microbiol 291(33):58–61PubMedCrossRef
176.
Kaiser R (2011) Langzeitprognose bei primär myelitischer Manifestation der FSME. Eine Verlaufsanalyse über 10 Jahre. Nervenarzt 82:1020–1025PubMedCrossRef
177.
Kamei S (2006) Trends in the management of herpes simplex encephalitis. Rinsho Shinkeigaku 46:950–953PubMed
178.
179.
Kutleša M, Baršić B (2012) Therapeutic hypothermia for severe adult Herpes simplex virus encephalitis. Wien Klin Wochenschr 124:855–858PubMedCrossRef
180.
Lee KE, Umapathi T, Tan CB et al (1999) The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus. Ann Neurol 464:28–32
181.
182.
Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bönstrup M, Havemeister S, Teegen B, Lütgehetmann M, Rosenkranz M, Magnus T, Dalmau J (2013) Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology 81:1637–1639PubMedPubMedCentralCrossRef
183.
Livorsi D, Anderson E, Qureshi S, Howard M, Wang YF, Paredes F-C (2010) Brainstem encephalitis: an unusual presentation of herpes simplex virus infection. J Neurol 257:1432–1437PubMedCrossRef
184.
Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K, Schielke E, Schmutzhard E, de Gans J, Chung CH, Luntz S, Hacke W, Meyding-Lamadé U (2008) Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial. BMC Neurol 8:40PubMedPubMedCentralCrossRef
185.
Meyding-Lamade UK, Lamade WR, Wildemann BT, Sarto K, Hacke W (1999) Herpes simplex virus encephalitis: chronic progressive cerebral magnetic resonance imaging abnormalities in patients despite good clinical recovery. Clin Infect Dis 28:148–149PubMedCrossRef
186.
Meyding-Lamadé U, Strank C (2012) Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord 5:279–296PubMedPubMedCentralCrossRef
187.
Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T (2010) Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 9:1097–1105PubMedCrossRef
188.
Porotto M, Rockx B, Yokoyama CC, Talekar A, Devito I, Palermo LM, Liu J, Cortese R, Lu M, Feldmann H, Pessi A (2010) Moscona A Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entr. PLoS Pathog 6:e1001168PubMedPubMedCentralCrossRef
189.
Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163:319–328PubMedCrossRef
190.
191.
Robert-Koch-Institut RKI– (2014) FSME: Risikogebiete in Deutschland. Epidemiol Bull 15:121–136
192.
Romero JR, Newland JG (2003) Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 14:72–82PubMedCrossRef
193.
Schmutzhard E (2001) Viral infections of the CNS with special emphasis on herpes simplex infections. J Neurol 248:469–477PubMedCrossRef
194.
Schwab S, Junger E, Spranger M, Dorfler A, Albert F, Steiner HH, Hacke W (1997) Craniectomy: an aggressive treatment approach in severe encephalitis. Neurology 48:412–417PubMedCrossRef
195.
Sener RN (2002) Diffusion MRI in Rasmussen’s encephalitis, herpes simplex encephalitis, and bacterial meningoencephalitis. Comput Med Imaging Graph 26:327–332PubMedCrossRef
196.
197.
Sköldenberg B, Forsgren M, Alestig K, Bergström T, Burman L, Dahlqvist E, Forkman A, Frydén A, Lövgren K, Norlin K et al (1984) Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet 29:707–711CrossRef
198.
Solomon T, Michael BD, Smith PE, Sanderson F, Davies NWS, Hart IJ, Holland M, Easton A, Buckley C, Kneen R, Beeching (2012) Management of suspected viral encephalitis in adults – Association of British Neurologists and British Infection Association National Guidelines. J Infection 64:347–373CrossRef
199.
Sommer JB, Heckmann JG, Kraus J, Neundörfer B, Erbguth FJ (2000) Generalized brain edema in non-purulent meningoencephalitis. The anti-edema effect of therapy with dexamethasone. Nervenarzt 71:112–115PubMedCrossRef
200.
Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG (2010) Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 17(999)
201.
Tan CT, Goh KJ, Wong KT et al (2002) Relapsed and late-onset Nipah encephalitis. Ann Neurol 51:703–708PubMedCrossRef
202.
Taskin E, Turgut M, Kilic M et al (2004) Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis. Mediators of Inflammation 13:269–273PubMedPubMedCentralCrossRef
203.
Thakur KT, Motta M, Asemota AO, Kirsch HL, Benavides D, Schneider EB, McArthur JC, Geocadin RG, Venkatesan A (2013) Predictors of outcome in acute encephalitis. Neurology 81:793–800PubMedPubMedCentralCrossRef
204.
Thomson RB Jr., Bertram H (2001) Laboratory diagnosis of central nervous system infections. Infect Dis Clin North Am 15:1047–1071PubMedCrossRef
205.
Tyler KL (2004) Update on herpes simplex encephalitis. Rev Neurol Dis 1:169–178PubMed
206.
207.
Utley TF, Ogden JA, Gibb A, McGrath N, Anderson NE (1997) The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors. Neuropsychiatry Neuropsychol Behav Neurol 10:180–189PubMed
208.
Wagner I, Staykov D, Volbers B, Kloska S, Dörfler A, Schwab S, Bardutzky J (2011) Mild hypothermia for space-occupying Herpes simplex virus encephalitis. Minerva Anestesiol 77:371–374PubMed
209.
Whitley RJ, Lakeman AD, Nahmias A, Roizman B (1982) Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med 307:1060–1062PubMedCrossRef
210.
Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ (1986) Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314:144–149PubMedCrossRef
211.
Whitley RJ, Gnann JW (2002) Viral encephalitis: familiar infections and emerging pathogens. Lancet 359:507–513PubMedCrossRef
212.
213.
Wildemann B, Ehrhart K, Storch-Hagenlocher B, Meyding-Lamade U, Steinvorth S, Hacke W, Haas J (1997) Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology 48:1341–1346PubMedCrossRef
214.
Wong M, Connolly AM, Noetzel MJ (1999) Poliomyelitis-like syndrome associated with Epstein-Barr virus infection. Pediatr Neurol 20:235–237PubMedCrossRef
215.
Wong KT, Shieh WJ, Kumar S et al (2002) Nipah Virus Pathology Working Group. Nipah virus Infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 161:2153–2167PubMedPubMedCentralCrossRef
216.
Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology 80:1430–1438PubMedPubMedCentralCrossRef
217.
218.
Brew BJ, Davies NW, Cinque P, Clifford DB, Nath A (2010) Progressive multifocal leukencephalopathy and other forms of JC virus disease. Nat Rev Neurol 6:667–679PubMedCrossRef
219.
Campbell H, Andrews N, Brown KE, Miller E (2007) Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 36:1334–1348PubMedCrossRef
220.
Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52:623–625PubMedCrossRef
221.
Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, Zhao Z, Duda P (2013) A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predic- tors of PML outcomes. J Neurovirol 19:351–358PubMedPubMedCentralCrossRef
222.
Dahlhaus S, Hoepner R, Chan A, Kleiter I, Adams O, Lukas C, Hellwig K, Gold R (2013) Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukencephalopathy patients. J Neurol Neurosurg Psychiatry 84:1068–1074PubMedPubMedCentralCrossRef
223.
Gasnault J, Costagliola D, Hendel-Chavez H, Dulioust A, Pakianather S, Mazet AA, de Goer de Herve MG, Lancar R, Lascaux AS, Porte L, Delfraissy JF, Taoufik Y, ANRS 125 Trial Team (2011) Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One 6(6):e20967–125PubMedPubMedCentralCrossRef
224.
Gorelik L, Lerner M, Bixler S et al (2010) Anti-JCV Antibodies: Implications for PML Risk Stratification. Ann Neurol 68:295–303PubMedCrossRef
225.
Hauser S et al (2006) Harrison’s Neurology in Clinical Medicine. McGraw-Hill, New York
226.
Helbok R, Broessner G, Pfauler B, Schmutzhard E (2009) Chronic meningitis. J Neurol 256:168–175PubMedCrossRef
227.
Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH, Swiss HIV Cohort Study (2009) Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis (48):1459–1466
228.
Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM (2011) Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage. PLoS Negl Trop Dis 5:e932PubMedPubMedCentralCrossRef
229.
Mentzer D, Prestel J, Adams O et al (2012) Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies. J Neurol Neurosurg Psychiatry 83:927–933PubMedCrossRef
230.
Molloy ES, Calabrese LH (2008) Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Autoimmun Rev 8:144–146PubMedCrossRef
231.
Nagoshi K, Sadakane A, Nakamura Y, Yamada M, Mizusawa H (2011) Duration of Prion Disease is Longer in Japan Than in Other Countries. J Epidemiol May 28, Epub ahead of print
232.
Owens GP, Ritchie AM, Gilden DH, Borgoon MP, Becker D, Bennet JL (2007) Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF. Neurology 68:1815–1819PubMedPubMedCentralCrossRef
233.
Schönberger K, Ludwig MS, Wildner M, Weissbrich B (2013) Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One 2013 Jul 9;8(7)
234.
Schwab N, Schneider-Hohendorf T, Posevitz V et al (2013) L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology 81:865–871PubMedCrossRef
235.
Sharma S, Kumar S (2010) Case report: Cervical spinal cord signal changes in a case of adult-onset subacute sclerosing panencephalitis. Indian J Radiol Imaging 20:202–204PubMedPubMedCentralCrossRef
236.
Simpson DM (2011) HIV-associated PML: Changing epidemiology and clinical approach. Cleve Clin J Med 78:24–27CrossRef
237.
Tatli B, Ekici B, Ozmen M (2010) Flurpirtine may Stopp the progressive course of subacute sclerosing panencephalitis. Med Hypotheses 75:576–577PubMedCrossRef
238.
Warnke C, Menge T, Hartung HP, Racke MK, Cravens PD, Bennett JL, Frohman EM, Greenberg BM, Zamvil SS, Gold R, Hemmer B, Kieseier BC, Stüve O (2010) Natalizumab and progressive multifocal leukencephalopathy: what are the causal factors and can it be avoided? Arch Neurol 67:923–930PubMedPubMedCentralCrossRef
239.
Warnke C, von Geldern G, Markwerth P, et al. (2014) Cerebrospinal Fluid JC Virus Antibody Index for Diagnosis of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Ann Neurol 2014, Apr 11 (epub ahead of print)
240.
Wattjes MP, Vennegoor A, Moster J, van Oosten BW, Barkhof F, Killestein J (2014) Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place? J Neurol 261:1139PubMedCrossRef
241.
242.
Yilmaz C, Caksen H, Yilmaz N, Güven HS, Bayram I (2007) Two cases of Subacute Sclerosing Panencephalitis associated with Brainstem involvement. Trop Pediatr 53:280–283CrossRef
243.
Yousry TA, Pelletier D, Cadavid D et al (2012) MRI pattern in natalizumab-associated progressive multifocal leukencephalopathy. Ann Neurol 72:779–787PubMedCrossRef
244.
Anduze-Faris BM, Fillet AM, Gozlan J, Lancar R, Boukli N, Gasnault J, Caumes E, Livartowsky J, Matheron S, Leport C, Salmon D, Costagliola D, Katlama C (2000) Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. Aids 14:517–524PubMedCrossRef
245.
Arendt G (2013) Neurologische Komplikationen der HIV-Infektion in der Ära antiretroviraler Kombinationstherapien (cART). Retroviren Bulletin 1:2013
246.
Babiker AG, Emery S, Fätkenheuer G, Gordin FM, Grund B, Lundgren JD, Neaton JD, Pett SL, Phillips A, Touloumi G et al (2013) Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clin Trials 10(1):5–S36CrossRef
247.
Bucher HC, Griffith L, Guyatt GH, Opravil M (1997) Meta-analysis of prophylactic treatments againts pneumocystis carinii and toxoplasma encephalitis. J Acquir Immune Defic Syndr Hum Retrovirol 15:104–114PubMedCrossRef
248.
Cardo DM, Culver DH, Ciesielsky CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM (1997) A case-control study of HIVseroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 337:1485–1490PubMedCrossRef
249.
Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41 (RR-17): 1–19
250.
Chaisson RE, Keruly JC, Moore RD (2000) Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. J Am Med Assoc 248:3128–3129CrossRef
251.
Dworkin MS, Wan PC, Hanson DL, Jones JL (1999) Progressive multifocal leucoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J Infect Dis 180:621–625PubMedCrossRef
252.
Henderson DK (1999) Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus. J Am Med Assoc 281:931–936CrossRef
253.
Hoffmann C, Rockstroh JK, Kamps BS (Hrsg) (2007) HIV.Net 2007. www.hiv.net. Steinhäuser, Wuppertal-Beyenburg
254.
Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (2010) UNAIDS Report on the global AIDS Epidemic 2010
255.
Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S et al (2008) Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65–70PubMedPubMedCentralCrossRef
256.
Louie M, Markowitz M (2002) Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective. Antiviral Res 55:15–25PubMedCrossRef
257.
Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167–1170PubMedCrossRef
258.
Panel on Antiretroviral Guidelines for Adult and Adolescents (2006) Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services. October 10, 2006: 1–113
259.
Portegies P, Solod L, Cinque P, Chaudhuri A, Begovac J, Everall I, Weber T, Bojar M, Martinez-Martin P, Kennedy PG (2004) Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol 11:297–304PubMedCrossRef
260.
Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE (2000) Practice guidelines for the management of cryptococcal disease. Infectious diseases Society of America. Clin Infect Dis 30:710–718PubMedCrossRef
261.
Sackto N, McArthur JC (1997) Prospects for therapy of HIV-associated neurologic diseases. J Neurovirol 3:89–101CrossRef
262.
Schabet M, Herrlinger U, Weller M, Bamberg M, Clemens R, Dichgans J (1997) Neue Entwicklungen in Diagnostik und Therapie primärer Non-Hodgkin-Lymphome des zentralen Nervensystems. Nervenarzt 68:298–308PubMedCrossRef
263.
Wildemann B, Haas J, Lynen N, Stingele K, Storch-Hagenlocher B (1998) Diagnosis of cytomegalovirus encephalitis in patients with AIDS by quantitation of cytomegalovirus genomes in cells of cerebrospinal fluid. Neurology 50:693–697PubMedCrossRef
270.
Balasegaram M, Harris S, Checchi F et al (2006) Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bulletin WHO 84:783–791
271.
Birbeck GL, Beare N, Lewallen S et al (2010) Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study. Am J Trop Med Hyg 82:231–234PubMedPubMedCentralCrossRef
272.
Birbeck GL, Molyneux ME, Kaplan PW et al (2010) Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 9:1173–1181PubMedPubMedCentralCrossRef
273.
Braakman H, Fred MM, van de Molengraft JJ et al (2006) Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology 66:1094–1096PubMedCrossRef
274.
Burgos JM, Begher S, Silva HM et al (2008) Molecular identification of Trypanosoma cruzi I tropism for central nervous system in Chagas reactivation due to AIDS. Am J Trop Med Hyg 78:294–297PubMed
275.
Carod-Artal FJ (2009) Tropical causes of epilepsy. Rev Neurol 49:475–482PubMed
276.
Chacko G (2010) Parasitic diseases of the central nervous system. Semin Diagn Pathol 27:167–185PubMedCrossRef
277.
Córdova E, Maiolo E, Corti M, Orduna T (2010) Neurological manifestations of Chagas’ disease. Neurol Res 32:238–244PubMedCrossRef
278.
Corpelet C, Vacher P, Coudore F et al (2005) Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin. Eur J Clin Microbiol Infect Dis 24:74–75PubMedCrossRef
279.
Dauriac-Le Masson V, Chochon F, Demeret S et al (2005) Toxocara canis meningomyelitis. J Neurol 252:1267–1268PubMedCrossRef
280.
Davis TME, White NJ, Looareesuwan S, Silamut K, Warrell DA (1988) Quinine pharmacokinetics in cerebral malaria: predicted plasma concentrations after rapid intravenous loading using a two compartment mode. Trans R Soc Trop Med Hyg 82:542–547PubMedCrossRef
281.
Del Brutto OH, Roos KL, Coffey CS et al (2006) Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel. Ann Intern Med 145:43–51PubMedCrossRef
282.
Deo I, Robledo L, Meza A et al (2000) Encephalitis due to a free-living amoeba (Balamuthia mandrillaris), case report with literature review. Surg Neurol 53:611–616CrossRef
283.
Dondorp AM, Fanello CI, Hendriksen IC et al (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomized trial. Lancet 376:1647–1657PubMedPubMedCentralCrossRef
284.
Dondorp A, Nosten F, Stepniewska K et al (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717–725PubMedCrossRef
285.
Ellrodt A, Halfon P, Le Bras P, Halimi P, Bouree P, Desi M, Caquet R (1987) Multifocal central nervous system lesions in three patients with trichinosis. Arch Neurol 44:432–434PubMedCrossRef
286.
287.
Elsheikha HM, Khan NA (2010) Protozoa traversal of the blood-brain barrier to invade the central nervous system. FEMS Microbiol 34:532–553CrossRef
288.
289.
Feely NM, Waghorn DJ, Dexter T, Gallen I, Chioidini P (2010) Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment. Anaesthesia 65:298–301PubMedCrossRef
290.
Garcia HH, Pretell EJ, Gilman RH et al (2004) A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350:249–258PubMedCrossRef
291.
Golenser J, McQuillain J, Hee L et al (2006) Conventional and experimental treatment of cerebral malaria. Internat J Parasitol 36:583–593CrossRef
292.
Hainard A, Tiberti N, Robin X et al (2011) Matrix metalloproteinase-9 and intercellulara adhesion molecule 1 are powerful staging markers for human African Trypanosomiasis. Trop Med Int Health 16:119–126PubMedCrossRef
293.
Helbok R, Brenneis C, Beer R et al (2007) A rare case of Toxocara canis cerebral vasculitis. Europ J Neurol 14:117–120CrossRef
294.
295.
Häselbarth K, Tenter AM, Brade V et al (2007) First case of human babesiosis in Germany – Clinical presentation and molecular characterisation of the pathogen. Internat J Med Microbiol 297:197–204CrossRef
296.
297.
Katchanov J, Nawa Y (2010) Helminthic invasion of the central nervous system: many roads lead to Rome. Parasitol Int 59:491–496PubMedCrossRef
298.
299.
Krishnan A, Karnad DR (2003) Severe falciparum malaria: an important cause of multiple organ failure in Indian intensive care unit patients. Crit Care Med 31:2278–2284PubMedCrossRef
300.
Khan NA (2010) Novel in vitro and in vivo models to study central nervous system infections due to Acanthamoeba spp. Exp Parasitol 126:69–72PubMedCrossRef
301.
Kristensson K, Nygard M, Bertini G, Bentivoglio (2010) African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions. Prog Neurobiol 91:152–171PubMedCrossRef
302.
Lackner P, Beer R, Broessner G et al (2010) Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient. Neurocrit Care 12:91–94PubMedCrossRef
303.
304.
305.
Lv S, Zhang Y, Steinmann P, Utzinger J (2010) Helminth infections of the central nervous system occurring in Southeast Asia and the Far East. Adv Parasitol 72:351–408PubMedCrossRef
306.
Mace SE (2010) Central nervous system infections as a cause of an altered mental status? What is the pathogen growing in your central nervous system? Emerg Med Clin North Am 28:535–570PubMedCrossRef
307.
Marr JJ, Docampo R (1986) Chemotherapy for Chagas’ disease: a perspective of current therapy and considerations for future research. Rev Infect Dis 8:884–903PubMedCrossRef
308.
Michal A, Regli F, Campiche R, Cavallo RJ, de Crousaz G, Oberson R, Rabinowicz T (1977) Cerebral coenurosis. Report of a case with arteritis. J Neurol 216:265–272PubMedCrossRef
309.
Michelet L, Fleury A, Sciutto E et al (2011) Human neurocysticercosis: Comparision of different diagnostic tests in cerebrospinal fluid. J Clin Microbiol 49:195–200PubMedCrossRef
310.
Molyneux ME, Taylor TE, Wirima JJ, Borgstein A (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. O J Med 71:441–459
311.
Nanda NC, Rath P, Acharya J, Mishra P, Mishra SK (2011) Falciparum Malaria in Children-A Brief Report of 305 Patients from Rourkela, Eastern India. Indian J Pediatr 78:475–477PubMedCrossRef
312.
Nkouawa A, Sako Y, Itoh S et al (2010) Serological studies of neurologic helminthic infections in rural areas of southwest Cameroon: toxocariasis, cysticercosis and paragonimiasis. PLoS Negl Trop Dis 4:e732PubMedPubMedCentralCrossRef
313.
Onyeyili PA, Onwualu JE (1991) Efficacy of combination of DFMO and diminazene aceturate in the treatment of late-stage Trypanosoma brucei infection in rats. Trop Med Parasitol 42:143–145PubMed
314.
Pitella JEH (1984) Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquiatr 42:105–115PubMedCrossRef
315.
Poltera AA (1985) Pathology of human African trypanosomiasis with reference to experimental African trypanosomiasis and infections of the central nervous system. Br Med Bull 41:169–174PubMed
316.
Potchen MJ, Birbeck GL, Demarco JK et al (2010) Neuroimaging findings in children with retinopathy-confirmed cerebral malaria. Eur J Radiol 74:262–268PubMedCrossRef
317.
318.
Saddler M, Barry M, Ternouth I, Emmanuel J (1990) Treatment of severe malaria by exchange transfusion. N Engl J Med 322:58CrossRef
319.
Saleem T, Rabbani M, Jamil B (2009) Primary amoebic meningoencephalitis: two new cases from Pakistan. Trop Doct 39:242–243PubMedCrossRef
320.
Sattar MA, Hoque HW, Amin MR, Faiz MA, Rahman MR (2009) Neurological findings and outcome in adult cerebral malaria. Bangladesh Med Res Counc Bull 35:15–17PubMedCrossRef
321.
Schmutzhard E (2010) Parasitic diseases of the central nervous system. Nervenarzt 81:162–171PubMedCrossRef
322.
Schmutzhard E (2006) Protozoal Infections. In: Noseworthy JH (Hrsg) Neurological Therapeutics – Principles and Practice. Informa Health Care, Abingdon, Oxon, S 1116–1132
323.
Schmutzhard E, Mayr U, Rumpl E, Prugger M, Pohl P (1986) Secondary cerebral amebiasis due to infection with Entamoeba histolytica. Eur Neurol 25:161–165PubMedCrossRef
324.
Schmutzhard E, Boongird P, Vejjajiva A (1988) Eosinophilic meningitis and radiculomyelitis in Thailand, caused by CNS invasion of Gnathostoma spingerum and Angiostrongylus cantonensis. J Neurol Neurosurg Psychiatry 51:80–87PubMedPubMedCentralCrossRef
325.
Scowden EB, Schaffner W, Stone WJ (1978) Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 57:527–544CrossRef
326.
Silva AA, Roffe E, Santiago H et al (2007) Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process. J Neuroimmunol 184:156–163PubMedCrossRef
327.
Solaymani-Mohammadi S, Lam MM, Zunt JR, Petri WA et al (2007) Entamoeba histolytica encephalitis diagnosed by PCR of cerebral spinal fluid. Trans R Soc Trop Med Hyg 101:311–313PubMedCrossRef
328.
Sotelo-Avila C (1987) Naegleria and Acanthamoeba. Free-living amebas pathogenic for man. Perspect Pediatr Pathol 10:51–58PubMed
329.
Taelman H, Schaechter PJ, Marcelis L (1987) Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Am J Med 82:607–614PubMedCrossRef
330.
Tran TH, Dolecek C, Pham PM et al (2004) Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363:18–22PubMedCrossRef
331.
Urbina JA, Docampo R (2003) Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasiotol 11:495–501CrossRef
332.
Utzinger J, Bergquist R, Olveda R, Zhou XN (2010) Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination. Adv Parasitol 72:1–30PubMedCrossRef
333.
Visvesvara GS (2010) Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. Curr Opin Infect Dis 23:590–594PubMedCrossRef
334.
Wang J, Qi H, Diao Z et al (2010) An outbreak of angiostrongyliasis cantonensis in Beijing. J Parasitol 96:377–381PubMedCrossRef
335.
Wang P, Wu MC, Chen SJ et al (2010) Research development of the pathogenesis pathways for neuroschistosomiasis. Neurosci Bull 26:168–174PubMedCrossRef
336.
Warrell DA, Looareesuwan S, Warrell MJ, Kasemarn P, Intaraprasert R, Bunnag D, Harinasuta T (1982) Dexamethasone proves deleterious in cerebral malaria. A double blind trial in 100 comatose patients. N Engl J Med 306:313–319PubMedCrossRef
337.
Watt G, Long GW, Ranoa CP, Adapon B, Fernando MT, Cross JH (1989) Praziquantel in treatment of cerebral schistosomiasis. Lancet 2:262–263
338.
Wenzler T, Boykin DW, Ismail MA et al (2009) New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289 Antimicrobiob Agents. Chemother 53:4185–4192
339.
Winkler AS, Willingham AL 3rd, Sikasunge CS et al (2009) Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr 3:3–12CrossRef
340.
Wittner M, Rowin KS, Tanowitz HB et al (1982) Successful chemotherapy of transfusion babesiosis. An Intern Med 96:601–604CrossRef
341.
World Health Organization (2000) Managment of Servere Malaria: A practical Handbook, 2. Aufl. World Health Organization, Geneva
342.
Zimmerman GA, Castro-Faria-Neto H (2010) Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies. Expert Rev Anti Infect Ther 8:1209–1212PubMedCrossRef
343.
344.
Abbott SP et al (1995) Fatal cerebral mycoses caused by the ascomycete Chaetomium strumarium. J Clin Microbiol 33:2692–2698PubMedPubMedCentral
345.
Al-Jehani H, Guiot MC, Torres C, Marcoux J (2010) Scedosporium cerebral abscesses after extra-corporeal membrane oxygenation. Can J Neurol Sci 37:671–678PubMedCrossRef
346.
Andreoni SC (2004) Medical Mycology Atlas. S-Systems, Milano
347.
Bennett JE (1987) Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis 9:398–402PubMedCrossRef
348.
Berger JR, Greenberg RN (2010) Isolated central nervous system histoplasmosis in an immunocompetent patient: 53-month hiatus to diagnosis and treatment. J Neurovirol 16:472–474PubMedCrossRef
349.
Black KE, Baden LR (2007) Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs 21:293–318PubMedCrossRef
350.
Blyth CC, Hale K, Palasanthiran P, O’Brian T, Bennett HMl (2010) Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. Cochrane Database Syst Rev Feb 17:CD006343
351.
Christophe C, Azzi N, Bouche B et al (1999) Magnetic resonance imaging and angiography in cerebral fungal vasculitis. Neuropediatrics 30:218–220PubMedCrossRef
352.
Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G et al (2005) Combined activity in vitro of Caspofungin, amphothericin B, and azole agents against itraconazloe-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Chemother 49:1232–1235PubMedPubMedCentralCrossRef
353.
Diekema DJ, Messer SA, Hollis RJ et al (2003) Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 41:3623–3626PubMedPubMedCentralCrossRef
354.
Dupont B (2002) Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother 49:31–36PubMedCrossRef
355.
Feltracco P, Barbieri S, Furnari M et al (2010) Central nervous system infectious complications early after liver transplantation. Transplant Proc 42:1216–1222PubMedCrossRef
356.
Fica A, Diaz MC, Luppi M (2003) Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana. Scand J Infect Dis 35:892–893PubMedCrossRef
357.
Friedman JA, Wijdicks EF, Fulgham JR (2000) Meningoencephalitis due to Blastomyces dermatitidis: case report and literature review. Mayo Clin Proc 75:403–408PubMedCrossRef
358.
Garcia RJ, Troya P, Edwards C (2006) Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review. South Med J 99:607–610PubMedCrossRef
359.
Glass HC, Wirrell E, Sarnat HB et al (2007) MRI findings in an immunocompromised boy with CNS fungal infection. Can J Neurol Sci 34:88–91PubMedCrossRef
360.
361.
Girmenia C, Martino P (2003) New antifungal drugs and new clinical trials: interpreting results may be difficult. Curr Opin Oncol 15:283–288PubMedCrossRef
362.
Herbrecht R, Denning DW, Paterson TF (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415PubMedCrossRef
363.
Javadi A, Ataei B, Koleini N, Saboori M (2010) Central nervous system aspergillosis in an immunocompetent patient. Neurosciences (Riyadh) 15:193–195
364.
Kowacs PA, Soares Silvado CE, Monteiro De Almeida S et al (2004) Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors. J Clin Pathol 57:205–207PubMedPubMedCentralCrossRef
365.
Labadie EL, Hamilton RH (1986) Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B. Arch Intern Med 146:2013–2018PubMedCrossRef
366.
Lazo A, Wilner HJ, Metes JJ (1981) Craniofacial mucormycosis: computed tomographic and angiographic findings in two cases. Radiology 139:623–626PubMedCrossRef
367.
Lowe JT, Hudson WR (1975) Rhinocerebral phycomycosis and internal carotid artery thrombosis. Arch Otolaryngol 101:100–103PubMedCrossRef
368.
Mathews M, Paré L, Hasso A (2007) Intraventricular cryptococcal cysts masquerading as racemose neurocysticercosis. Surg Neurol 67:647–649PubMedCrossRef
369.
Mazumder SA, Cleveland KO (2010) Cryptococcal meningitis after neurosurgery. Am J Med Sci 339:582–583PubMedCrossRef
370.
Moen MD, Lyseng-Willliamson KA, Scott LJ (2009) Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 69:361–392PubMedCrossRef
371.
Munoz P, Valerio M, Palomo J et al (2010) Infectious and non-infectious neurologic complications in heart transplant recipients. Medicine (Baltimore) 89:166–175CrossRef
372.
Mylonakis E, Paliou M, Sax PE et al (2000) Central nervous system aspergillosis in patients with human iummuno-defficiency virus infection. Medicine 79:269–280PubMedCrossRef
373.
Nevado J, De Alarcon A, Hernandez A (2005) Caspofungin: a new therapeutic option for fungal endocarditis. Clin Microbiol Infect 11:248–252PubMedCrossRef
374.
Perea JR, Diaz De Rada BS, Quetglas EG et al (2004) Oral versus intravneous therapy in the treatment of systemic mycosis. Clin Microbiol Infect 1:96–106CrossRef
375.
Perlroth J, Choi B, Spellberg B (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45:321–346PubMedCrossRef
376.
Pfausler, Kampfl A, Berek K, Maier H, Aichner F, Schmutzhard E (1995) Syndrome of the Anterior Spinal Artery as the Primary Manifestation of Aspergillosis. Infection 23:240–242PubMedCrossRef
377.
Purkins L, Wood N, Ghahramani P et al (2003) Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration. Br J Clin Pharmacol 1:37–44CrossRef
378.
Raman Sharma R (2010) Fungal infections of the nervous system: current perspective and controversies in management. Int J Surg 8:591–601PubMedCrossRef
379.
Ramesha KN, Kate MP, Kesavadas C et al (2010) Fungal infections of the central nervous system in HIV-negative patients: experience from a tertiary referral center of South India. Ann Indian Acad Neurol 13:112–116PubMedPubMedCentralCrossRef
380.
Raparia K, Powell SZ, Cernoch P, Takei H (2010) Cerebral mycosis: 7-year retrospective series in a tertiary center. Neuropathology 30:218–223PubMedCrossRef
381.
Revankar SG, Sutton DA, Rinaldi MG (2004) Primary central nervous system phaeohyphomycocis: a review of 101 cases. Clin Infect Dis (38):206–216
382.
Rubio MC, de Ocariz IR, Gil J et al (2005) Potential fungicidal effect of voriconazole against Candida spp. Int J Antimicrob Agents 25:264–267PubMedCrossRef
383.
Ruchel R et al (1995) Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 38:473–475PubMedCrossRef
384.
Sakhuja V, Sud K, Kalra OP et al (2001) Central nervous system complications in renal transplant recipients in a tropical environment. J Neurol Sci 183:89–93PubMedCrossRef
385.
Sasaki T, Mineta M, Kobayashi K, Ando M, Obata M (2010) Zygomycotic invasion of the central nervous system. Jpn J Radiol 28:376–80PubMedCrossRef
386.
Schmutzhard E (2006) Fungal Infections. In: Noseworthy JH (Hrsg) Neurological Therapeutics-Principles and Practice. Informa Healthcare, Abingdon, Oxon, S 1085–1115
387.
388.
Senzolo M, Ferronato C, Burra P (2009) Neurologic complications after solid organ transplantation. Transpl Int 22:269–278PubMedCrossRef
389.
Shamin MS, Enam SA, Ali R, Anwar S (2010) Craniocerebral aspergillosis: a review of advances in diagnosis and management. J Pak Med Assoc 60:573–579
390.
Siegal JA, Cacayorinb ED, Nassif AS et al (2000) Cerebral mucormycosis: proton MR spectroscopy and MR imaging. Magn Reson Imaging 18:915–920PubMedCrossRef
391.
Sun HY, Forrest G, Gupta KL et al (2010) Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation 15:85–92CrossRef
392.
Van Hal SJ, Clezy K (2005) Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy. HIV Med 6:45–46PubMedCrossRef
393.
Varanasi NL, Baskaran I, Alangaden GJ et al (2004) Novel effect of voriconazole on conidiation of Aspergillus species. Int J Antimicrob Agens 23:72–79CrossRef
394.
Vos MJ, Debets-Ossenkopp YJ, Claessen FA et al (2000) Cerebellar and medullar histoplasmosis. Neurology 54:1441PubMedCrossRef
395.
Weng CT, Lee NY, Liu MF et al (2010) A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan. Lupus 19:1204–1209PubMedCrossRef
396.
Wingard JR, Leather H (2004) A new era of antifungal therapy. Biol Blood Marrow Transplant 10:73–90PubMedCrossRef
397.
Zivkovic (2007) Neuroimaging and neurologic complications after organ transplantation. J Neuroimaging 17:110–23PubMedCrossRef
398.
Alhelm F et al (2006) Spondylitis/Spondylodiszitis. Radiologe 46:480–485CrossRef
399.
Belzunegui J et al (1999) Vertebral osteomyelitis in northern Spain. Report of 62 cases. Clin Exp Rheumatol 177:447–452
400.
Beronius M, Bergman B, Andersson R (2001) Vertebral osteomyelitis in Göteborg, Sweden: a retrospective study of patients during 1990–95. Scand J Infect Dis 33:527–532PubMedCrossRef
401.
Chelsom J, Solberg CO (1998) Vertebral osteomyelitis at a Norwegian university hospital 1987–97: clinical features, laboratory findings and outcome. Scand J Infect Dis 30:147–151PubMedCrossRef
402.
Cordonnier C et al (2003) Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 250:1447–1452PubMedCrossRef
403.
Debette S, de Sèze J, Pruvo J-P, Zephir H, Pasquier F, Leys D, Vermersch P (2009) Long-term outcome of acute and subacute myelopathies. J Neurol 256:980–988PubMedCrossRef
404.
De Seze J et al (2001) Acute Myelopathies. Clinical. Laboratory and outcome profiles in 79 patients. Brain 124:1509–1521PubMedCrossRef
405.
Duncan S, Halfpenny C, Galea I (2014) CNS inflammation other than multiple sclerosis: How likely is diagnosis? Neurology 82:1187–1189CrossRef
406.
Erickson BJ, Weinshenker BG (2010) Compressive myelopathy mimicking transverse myelitis. Neurologist 16:120–122PubMedCrossRef
407.
Frohmann EM, Wingerchuk DM (2010) Clinical Practice. Transverse Myelitis. N Engl J Med 363:564–572CrossRef
408.
Grabowski A (2013) Manual Neurologische Akut- und Intensivmedizin. Schattauer, Stuttgart
409.
Greenberg BM et al (2007) Idiopathic transverse myelitis. Corticosteroids, plasma exchange, or cyclophosphamid. Neurology 68:1614–1617PubMedCrossRef
410.
411.
412.
Irani DN, Kerr DA (2000) 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 355(9207):901PubMedCrossRef
413.
Jacob A, Weinshenker BG (2008) An Approach to the Diagnosis of Acute Tranverse Myelitis. Semin Neurol 28:105–120PubMedCrossRef
414.
Kalita J, Misra UK, Mandal SK (1998) Prognostic predictors of acute transverse myelitis. Acta Neurol Scand 98:60–63PubMedCrossRef
415.
Kalita J, Misra UK (2000) Neurophysiological studies in acute transverse myelitis. J Neurol 247:943–948PubMedCrossRef
416.
Kalita J, Misra UK (2001) Is methyl prednisolone useful in acute transverse myelitis? Spinal Cord 39:471–476PubMedCrossRef
417.
Karussis D, Petrou P (2014) The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimm Rev 13:215–224CrossRef
418.
Krishnan C et al (2004) Transverse Myelitis: pathogenesis, diagnosis and treatment. Front Biosci 9:1483–1499PubMedCrossRef
419.
Lewis M, Howdle (2003) The neurology of liver failure. Q J Med 96:623–633CrossRef
420.
Mealy M, Wingerchuck D, Palace J, Greenberg B, Levy B (2014) Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica. Multicenter Study of Treatment Efficacy. JAMA Neurology 71:324–330PubMedCrossRef
421.
Meyding-Lamadé U et al (2005) Akute spinale Entzündungen. Intensivmed 42:337–344CrossRef
422.
423.
Schellinger PD, Schmutzhard E, Fiebach JB, Pfausler B, Maier H, Schwab S (2000) Poliomyelitic-like illness in central european encephalitis. Neurology 55:299–302PubMedCrossRef
424.
Schlossbauer T, Panteleon A, Becker-Gaab C (2006) Entzündliche Wirbelsäulenerkrankungen als Ursache für Rückenschmerzen. Radiologe 46:468–479PubMedCrossRef
425.
Schmalstieg W, Weinshenker BG (2010) Approach to acute or subacute myelopathy. Neurology Clinical Practice 75(1):2–S8
426.
Sellner J et al (2010) EFNS Guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17:1019–1032PubMedCrossRef
427.
Transverse Myelitis Consortium Working Group Neurology (2002) Proposed diagnostic citeria and nosology of acute tranverse myelitis. Neurology 59:499–505CrossRef
428.
West T, Hess C, Cree B (2012) Acute transverse Myelitis: Demyelinating, Inflammatory, and infectious Myelopathies. Semin Neurol 32:97–113PubMedCrossRef
429.
430.
Metadaten
Titel
Infektionen
verfasst von
Matthias Klein, PD Dr.
Hans-Walter Pfister, Prof. Dr.
Erich Schmutzhard, Prof. Dr.
Uta Meyding-Lamadé, Prof. Dr.
Corinna Schranz, Dr.
Gabriele Arendt, Prof. Dr.
Raimund Helbok, PD Dr.
Bettina Pfausler, PD Dr.
André Grabowski, Dr.
Bodo Kress, Prof. Dr.
Ronny Beer, PD Dr.
Copyright-Jahr
2015
Verlag
Springer Berlin Heidelberg
Buch
NeuroIntensiv

Print ISBN: 978-3-662-46499-1

Electronic ISBN: 978-3-662-46500-4

Copyright-Jahr: 2015

DOI
https://doi.org/10.1007/978-3-662-46500-4_32

Neu im Fachgebiet AINS

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise